{
    "$schema": "https://github.com/Open-Systems-Pharmacology/QualificationPlan/releases/download/v3.3/OSP_Qualification_Plan_Schema.json",
    "Projects": [
        {
            "Id": "Rifampicin",
            "Path": "../../Rifampicin-Model.json",
            "BuildingBlocks": [],
            "SimulationParameters": []
        }
    ],
    "ObservedDataSets": [],
    "Plots": {
        "AxesSettings": {
            "GOFMergedPlotsPredictedVsObserved": [
                {
                    "Type": "X",
                    "Dimension": "Concentration (mass)",
                    "Unit": "µg/l",
                    "GridLines": false,
                    "Scaling": "Log"
                },
                {
                    "Type": "Y",
                    "Dimension": "Concentration (mass)",
                    "Unit": "µg/l",
                    "GridLines": false,
                    "Scaling": "Log"
                }
            ],
            "GOFMergedPlotsResidualsOverTime": [
                {
                    "Type": "X",
                    "Dimension": "Time",
                    "Unit": "h",
                    "GridLines": false,
                    "Scaling": "Linear"
                },
                {
                    "Type": "Y",
                    "Dimension": "Dimensionless",
                    "Unit": "",
                    "GridLines": false,
                    "Scaling": "Linear"
                }
            ],
            "ComparisonTimeProfile": [
                {
                    "Type": "X",
                    "Dimension": "Time",
                    "Unit": "h",
                    "GridLines": false,
                    "Scaling": "Linear"
                },
                {
                    "Type": "Y",
                    "Dimension": "Concentration (mass)",
                    "Unit": "µg/l",
                    "GridLines": false,
                    "Scaling": "Log"
                }
            ],
            "DDIRatioPlotsPredictedVsObserved": [
                {
                    "Type": "X",
                    "Dimension": "Dimensionless",
                    "Unit": "",
                    "GridLines": false,
                    "Scaling": "Log"
                },
                {
                    "Type": "Y",
                    "Dimension": "Dimensionless",
                    "Unit": "",
                    "GridLines": false,
                    "Scaling": "Log"
                }
            ],
            "DDIRatioPlotsResidualsVsObserved": [
                {
                    "Type": "X",
                    "Dimension": "Dimensionless",
                    "Unit": "",
                    "GridLines": false,
                    "Scaling": "Log"
                },
                {
                    "Type": "Y",
                    "Dimension": "Dimensionless",
                    "Unit": "",
                    "GridLines": false,
                    "Scaling": "Log"
                }
            ],
            "PKRatioPlots": [
                {
                    "Type": "X",
                    "Dimension": "Age",
                    "Unit": "year(s)",
                    "GridLines": false,
                    "Scaling": "Linear"
                },
                {
                    "Type": "Y",
                    "Dimension": "Dimensionless",
                    "Unit": "",
                    "GridLines": false,
                    "Scaling": "Log"
                }
            ]
        },
        "PlotSettings": {
            "ChartWidth": 500,
            "ChartHeight": 400,
            "Fonts": {
                "AxisSize": 11,
                "LegendSize": 9,
                "OriginSize": 9,
                "FontFamilyName": "Arial",
                "WatermarkSize": 40
            }
        },
        "AllPlots": [
            {
                "SectionReference": "ct-profiles",
                "Project": "Rifampicin",
                "Simulation": "Rifampicin iv 300 mg (0.5 h)"
            },
            {
                "SectionReference": "ct-profiles",
                "Project": "Rifampicin",
                "Simulation": "Rifampicin iv 300 mg (3 h)"
            },
            {
                "SectionReference": "ct-profiles",
                "Project": "Rifampicin",
                "Simulation": "Rifampicin iv 450 mg (3 h)"
            },
            {
                "SectionReference": "ct-profiles",
                "Project": "Rifampicin",
                "Simulation": "Rifampicin iv 600 mg (0.5 h)"
            },
            {
                "SectionReference": "ct-profiles",
                "Project": "Rifampicin",
                "Simulation": "Rifampicin iv 600 mg (3 h)"
            },
            {
                "SectionReference": "ct-profiles",
                "Project": "Rifampicin",
                "Simulation": "Rifampicin iv 600 mg (3 h) MD OD (7 days)"
            },
            {
                "SectionReference": "ct-profiles",
                "Project": "Rifampicin",
                "Simulation": "Rifampicin po 300 mg"
            },
            {
                "SectionReference": "ct-profiles",
                "Project": "Rifampicin",
                "Simulation": "Rifampicin po 450 mg"
            },
            {
                "SectionReference": "ct-profiles",
                "Project": "Rifampicin",
                "Simulation": "Rifampicin po 450 mg MD OD (7 days)"
            },
            {
                "SectionReference": "ct-profiles",
                "Project": "Rifampicin",
                "Simulation": "Rifampicin po 600 mg"
            },
            {
                "SectionReference": "ct-profiles",
                "Project": "Rifampicin",
                "Simulation": "Rifampicin po 600 mg MD OD (7 days)"
            }
        ],
        "GOFMergedPlots": [
            {
                "SectionReference": "diagnostics-plots",
                "Title": "Rifampicin concentration in plasma/serum",
                "PlotTypes": [
                    "predictedVsObserved",
                    "residualsOverTime"
                ],
                "Groups": [
                    {
                        "Caption": "Rifampicin iv",
                        "Symbol": "Circle",
                        "OutputMappings": [
                            {
                                "Project": "Rifampicin",
                                "Simulation": "Rifampicin iv 300 mg (0.5 h)",
                                "Output": "Organism|PeripheralVenousBlood|Rifampicin|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "sanofi-aventis U.S. LLC. 2013 - 300 mg - Rifampicin - IV - 300 mg - Plasma - agg. (n=12)",
                                "Color": "#FF0000"
                            },
                            {
                                "Project": "Rifampicin",
                                "Simulation": "Rifampicin iv 300 mg (3 h)",
                                "Output": "Organism|PeripheralVenousBlood|Rifampicin|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Nitti 1977 - 300 mg - Rifampicin - IV - 300 mg - Serum - agg. (n=2)",
                                "Color": "#FF0000"
                            },
                            {
                                "Project": "Rifampicin",
                                "Simulation": "Rifampicin iv 450 mg (3 h)",
                                "Output": "Organism|PeripheralVenousBlood|Rifampicin|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Nitti 1977 - 450 mg - Rifampicin - IV - 450 mg - Serum - agg. (n=3)",
                                "Color": "#FF0000"
                            },
                            {
                                "Project": "Rifampicin",
                                "Simulation": "Rifampicin iv 600 mg (0.5 h)",
                                "Output": "Organism|PeripheralVenousBlood|Rifampicin|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "sanofi-aventis U.S. LLC. 2013 - 600 mg - Rifampicin - IV - 600 mg - Plasma - agg. (n=12)",
                                "Color": "#FF0000"
                            },
                            {
                                "Project": "Rifampicin",
                                "Simulation": "Rifampicin iv 600 mg (3 h)",
                                "Output": "Organism|PeripheralVenousBlood|Rifampicin|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Nitti 1977 - 600 mg - Rifampicin - IV - 600 mg - Serum - agg. (n=6)",
                                "Color": "#FF0000"
                            },
                            {
                                "Project": "Rifampicin",
                                "Simulation": "Rifampicin iv 600 mg (3 h) MD OD (7 days)",
                                "Output": "Organism|PeripheralVenousBlood|Rifampicin|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Acocella 1977 - mean 600 mg MD - Rifampicin - IV - 600 mg - Serum - agg. (n=5)",
                                "Color": "#FF0000"
                            }
                        ]
                    },
                    {
                        "Caption": "Rifampicin po",
                        "Symbol": "Square",
                        "OutputMappings": [
                            {
                                "Project": "Rifampicin",
                                "Simulation": "Rifampicin po 300 mg",
                                "Output": "Organism|PeripheralVenousBlood|Rifampicin|Plasma (Peripheral Venous Blood)",
                                "ObservedData": [
                                    "Chouchane 1995 - Rimactan - Rifampicin - PO - 300 mg - Plasma - agg. (n=12)",
                                    "Chouchane 1995 - Rifampicin Generic - Rifampicin - PO - 300 mg - Plasma - agg. (n=12)",
                                    "Furesz 1970 - 300 mg - Rifampicin - PO - 300 mg - Serum - agg. (n=5)"
                                ],
                                "Color": "#1B64AE"
                            },
                            {
                                "Project": "Rifampicin",
                                "Simulation": "Rifampicin po 450 mg",
                                "Output": "Organism|PeripheralVenousBlood|Rifampicin|Plasma (Peripheral Venous Blood)",
                                "ObservedData": [
                                    "Blume 1989 - 450 mg REFERENZ - Rifampicin - PO - 450 mg - Plasma - agg. (n=8)",
                                    "Furesz 1970 - 450 mg - Rifampicin - PO - 450 mg - Serum - agg. (n=13)"
                                ],
                                "Color": "#1B64AE"
                            },
                            {
                                "Project": "Rifampicin",
                                "Simulation": "Rifampicin po 450 mg MD OD (7 days)",
                                "Output": "Organism|PeripheralVenousBlood|Rifampicin|Plasma (Peripheral Venous Blood)",
                                "ObservedData": [
                                    "Acocella 1972a - day 1 - Rifampicin - PO - 450 mg - Serum - agg. (n=5)",
                                    "Acocella 1972a - day 7 - Rifampicin - PO - 450 mg - Serum - agg. (n=5)"
                                ],
                                "Color": "#1B64AE"
                            },
                            {
                                "Project": "Rifampicin",
                                "Simulation": "Rifampicin po 600 mg",
                                "Output": "Organism|PeripheralVenousBlood|Rifampicin|Plasma (Peripheral Venous Blood)",
                                "ObservedData": [
                                    "Peloquin 1997 - 600 mg - Rifampicin - PO - 600 mg - Plasma - agg. (n=24)",
                                    "Blume 1989 - 600 mg REFERENZ - Rifampicin - PO - 600 mg - Plasma - agg. (n=12)",
                                    "Acocella 1972b - normal subjects - Rifampicin - PO - 600 mg - Serum - agg. (n=6)",
                                    "Eon Labs Manufacturing, Inc. 1997 - 2X300mg Rifadine Tab - Rifampicin - PO - 600 mg - Plasma - agg. (n=36)",
                                    "Peloquin 1997 - 600 mg - Rifampicin - PO - 600 mg - Plasma - agg. (n=24)"
                                ],
                                "Color": "#1B64AE"
                            },
                            {
                                "Project": "Rifampicin",
                                "Simulation": "Rifampicin po 600 mg MD OD (7 days)",
                                "Output": "Organism|PeripheralVenousBlood|Rifampicin|Plasma (Peripheral Venous Blood)",
                                "ObservedData": [
                                    "Baneyx 2014 - Day 4 - 600 mg po MD - Rifampicin - PO - 600 mg - Plasma - agg. (n=12)",
                                    "Baneyx 2014 - Day 7 - 600 mg po MD - Rifampicin - PO - 600 mg - Plasma - agg. (n=12)"
                                ],
                                "Color": "#1B64AE"
                            }
                        ]
                    }
                ]
            }
        ],
        "ComparisonTimeProfilePlots": [],
        "DDIRatioPlots": [],
        "PKRatioPlots": []
    },
    "Inputs": [
        {
            "Project": "Rifampicin",
            "Name": "Rifampicin",
            "Type": "Compound",
            "SectionReference": "final-input-parameters"
        }
    ],
    "Sections": [
        {
            "Reference": "introduction",
            "Title": "Introduction",
            "Content": "Content/Section1_Introduction.md"
        },
        {
            "Reference": "methods",
            "Title": "Methods",
            "Content": "Content/Section2_Methods.md",
            "Sections": [
                {
                    "Reference": "modeling-strategy",
                    "Title": "Modeling Strategy",
                    "Content": "Content/Section2.1_Modeling_Strategy.md"
                },
                {
                    "Reference": "data",
                    "Title": "Data",
                    "Content": "Content/Section2.2_Data.md"
                },
                {
                    "Reference": "model-parameters-and-assumptions",
                    "Title": "Model Parameters and Assumptions",
                    "Content": "Content/Section2.3_Model_Parameters_and_Assumptions.md"
                }
            ]
        },
        {
            "Reference": "results-and-discussion",
            "Title": "Results and Discussion",
            "Content": "Content/Section3_Results_and_Discussion.md",
            "Sections": [
                {
                    "Reference": "final-input-parameters",
                    "Title": "Final input parameters",
                    "Content": "Content/Input_table.md"
                },
                {
                    "Reference": "diagnostics-plots",
                    "Title": "Diagnostics Plots",
                    "Content": "Content/GOF_diagnostics.md"
                },
                {
                    "Reference": "ct-profiles",
                    "Title": "Concentration-Time Profiles",
                    "Content": "Content/Concentration_time_profiles.md"
                }
            ]
        },
        {
            "Reference": "conclusion",
            "Title": "Conclusion",
            "Content": "Content/Section4_Conclusion.md"
        },
        {
            "Reference": "main-references",
            "Title": "References",
            "Content": "Content/References.md"
        }
    ],
    "Intro": [
        {
            "Path": "Content/titlepage.md"
        }
    ]
}